Meldoz

Alendronate Sodium Trihydrate, the active ingredient in Meldoz, is a bisphosphonate presented as an oral tablet for systemic use. It works by inhibiting bone resorption and is indicated for the treatment of osteoporosis and Paget's disease of bone in adults who are at increased risk of fractures.

GNH USA supplies Meldoz as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Meldoz (alendronate) belongs to the bisphosphonate class and is used to manage diseases characterized by excessive bone turnover. - Osteoporosis: reduces the risk of vertebral, hip and other fractures by strengthening bone mass. - Paget's disease of bone: normalizes abnormal bone remodeling and alleviates bone pain. - Glucocorticoid‑induced osteoporosis: helps maintain bone density in patients receiving long‑term corticosteroid therapy.

Common Side Effects: - Abdominal pain: discomfort or cramping in the stomach area. - Dyspepsia: indigestion or a feeling of fullness. - Nausea: sensation of wanting to vomit. - Musculoskeletal pain: aches in muscles or joints.

Serious or Rare Side Effects: - Esophageal ulceration or erosion: painful lesions in the esophagus. - Osteonecrosis of the jaw: exposed bone in the jaw region, often after dental procedures. - Atypical femur fracture: unusual break in the thigh bone occurring with minimal trauma.

Before initiating therapy, clinicians should consider several safety measures. - Renal function assessment: evaluate creatinine clearance to ensure safe use. - Upright posture after dosing: remain seated or standing for at least 30 minutes to reduce esophageal irritation. - Calcium and vitamin D status: ensure adequate supplementation to support bone health. - Concomitant NSAID or corticosteroid use: monitor for increased gastrointestinal risk. - Storage: Store at room temperature: keep in the original pack, protect from moisture and heat.

Alendronate may interact with several medicines that affect its absorption or increase adverse effects. Major Interactions (Avoid): - Antacids containing calcium, magnesium or aluminum: bind the drug and markedly reduce its bioavailability. - Calcium supplements taken within 2 hours of alendronate: interfere with absorption. - Oral tetracycline antibiotics: chelate with alendronate and diminish effectiveness. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of gastrointestinal irritation. - Systemic corticosteroids: can exacerbate bone loss and should be used with caution.